COLLEGIUM PHARMACEUTICAL INC (COLL)
US19459J1043 - Common Stock
We assign a fundamental rating of 6 out of 10 to COLL. COLL was compared to 193 industry peers in the Pharmaceuticals industry. While COLL has a great profitability rating, there are quite some concerns on its financial health. COLL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
COLL had positive earnings in the past year.
COLL had a positive operating cash flow in the past year.
In multiple years COLL reported negative net income over the last 5 years.
In the past 5 years COLL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.42%, COLL belongs to the top of the industry, outperforming 89.01% of the companies in the same industry.
COLL's Return On Equity of 37.82% is amongst the best of the industry. COLL outperforms 95.81% of its industry peers.
COLL has a Return On Invested Capital of 10.46%. This is amongst the best in the industry. COLL outperforms 89.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for COLL is significantly below the industry average of 43.18%.
The 3 year average ROIC (8.70%) for COLL is below the current ROIC(10.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 37.82% | ||
| ROIC | 10.46% |
ROA(3y)4.14%
ROA(5y)1.83%
ROE(3y)15.68%
ROE(5y)7.1%
ROIC(3y)8.7%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of COLL (14.78%) is better than 89.53% of its industry peers.
COLL's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 32.29%, COLL belongs to the best of the industry, outperforming 95.29% of the companies in the same industry.
COLL's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 62.36%, COLL is doing good in the industry, outperforming 68.59% of the companies in the same industry.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.29% | ||
| PM (TTM) | 14.78% | ||
| GM | 62.36% |
OM growth 3Y19.53%
OM growth 5YN/A
PM growth 3Y-0.58%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y7.07%
2. Health
2.1 Basic Checks
COLL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
COLL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, COLL has less shares outstanding
COLL has a better debt/assets ratio than last year.
2.2 Solvency
COLL has an Altman-Z score of 1.00. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.00, COLL perfoms like the industry average, outperforming 58.64% of the companies in the same industry.
The Debt to FCF ratio of COLL is 4.51, which is a neutral value as it means it would take COLL, 4.51 years of fcf income to pay off all of its debts.
COLL has a better Debt to FCF ratio (4.51) than 89.01% of its industry peers.
COLL has a Debt/Equity ratio of 3.43. This is a high value indicating a heavy dependency on external financing.
COLL's Debt to Equity ratio of 3.43 is on the low side compared to the rest of the industry. COLL is outperformed by 84.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.43 | ||
| Debt/FCF | 4.51 | ||
| Altman-Z | 1 |
ROIC/WACC1.07
WACC9.77%
2.3 Liquidity
COLL has a Current Ratio of 0.97. This is a bad value and indicates that COLL is not financially healthy enough and could expect problems in meeting its short term obligations.
COLL has a Current ratio of 0.97. This is amonst the worse of the industry: COLL underperforms 86.39% of its industry peers.
COLL has a Quick Ratio of 0.97. This is a bad value and indicates that COLL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.88, COLL is not doing good in the industry: 83.77% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 3566.67% over the past year.
The Earnings Per Share has been growing by 15.79% on average over the past years. This is quite good.
Looking at the last year, COLL shows a quite strong growth in Revenue. The Revenue has grown by 9.63% in the last year.
Measured over the past years, COLL shows a quite strong growth in Revenue. The Revenue has been growing by 15.11% on average per year.
EPS 1Y (TTM)3566.67%
EPS 3Y15.79%
EPS 5YN/A
EPS Q2Q%203.77%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y22.28%
Revenue growth 5Y15.11%
Sales Q2Q%16.52%
3.2 Future
The Earnings Per Share is expected to grow by 46.17% on average over the next years. This is a very strong growth
COLL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.94% yearly.
EPS Next Y432.73%
EPS Next 2Y138.45%
EPS Next 3Y82.97%
EPS Next 5Y46.17%
Revenue Next Year11.36%
Revenue Next 2Y14.45%
Revenue Next 3Y10.41%
Revenue Next 5Y2.94%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 5.40, the valuation of COLL can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 96.34% of the companies listed in the same industry.
COLL is valuated cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
COLL is valuated cheaply with a Price/Forward Earnings ratio of 4.43.
COLL's Price/Forward Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 97.38% of the companies in the same industry.
COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.4 | ||
| Fwd PE | 4.43 |
4.2 Price Multiples
95.81% of the companies in the same industry are more expensive than COLL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 96.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.98 | ||
| EV/EBITDA | 4.75 |
4.3 Compensation for Growth
COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COLL has an outstanding profitability rating, which may justify a higher PE ratio.
COLL's earnings are expected to grow with 82.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y138.45%
EPS Next 3Y82.97%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COLLEGIUM PHARMACEUTICAL INC
NASDAQ:COLL (12/20/2024, 8:03:35 PM)
After market: 30 +0.3 (+1.01%)29.7
-0.74 (-2.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners126.05%
Inst Owner Change-2.2%
Ins Owners0.82%
Ins Owner Change1.28%
Market Cap957.83M
Analysts80
Price Target43.1 (45.12%)
Short Float %19.25%
Short Ratio14.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.03%
Min EPS beat(2)-0.88%
Max EPS beat(2)6.95%
EPS beat(4)3
Avg EPS beat(4)19.84%
Min EPS beat(4)-0.88%
Max EPS beat(4)51.47%
EPS beat(8)5
Avg EPS beat(8)-25.67%
EPS beat(12)6
Avg EPS beat(12)-31.34%
EPS beat(16)6
Avg EPS beat(16)-34.48%
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-1.05%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-3.25%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-0.96%
Revenue beat(12)5
Avg Revenue beat(12)-5.91%
Revenue beat(16)6
Avg Revenue beat(16)-5.15%
PT rev (1m)-2.31%
PT rev (3m)-0.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.52%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)19.16%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)1.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.4 | ||
| Fwd PE | 4.43 | ||
| P/S | 1.6 | ||
| P/FCF | 4.98 | ||
| P/OCF | 4.95 | ||
| P/B | 4.09 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.75 |
EPS(TTM)5.5
EY18.52%
EPS(NY)6.71
Fwd EY22.59%
FCF(TTM)5.97
FCFY20.09%
OCF(TTM)6.01
OCFY20.22%
SpS18.58
BVpS7.26
TBVpS-26.62
PEG (NY)0.01
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 37.82% | ||
| ROCE | 16.46% | ||
| ROIC | 10.46% | ||
| ROICexc | 11.65% | ||
| ROICexgc | N/A | ||
| OM | 32.29% | ||
| PM (TTM) | 14.78% | ||
| GM | 62.36% | ||
| FCFM | 32.11% |
ROA(3y)4.14%
ROA(5y)1.83%
ROE(3y)15.68%
ROE(5y)7.1%
ROIC(3y)8.7%
ROIC(5y)N/A
ROICexc(3y)14.87%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.69%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y24.23%
ROICexc growth 5YN/A
OM growth 3Y19.53%
OM growth 5YN/A
PM growth 3Y-0.58%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y7.07%
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.43 | ||
| Debt/FCF | 4.51 | ||
| Debt/EBITDA | 2.35 | ||
| Cap/Depr | 0.84% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | 3.08 | ||
| Cash Conversion | 56.69% | ||
| Profit Quality | 217.22% | ||
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 1 |
F-Score6
WACC9.77%
ROIC/WACC1.07
Cap/Depr(3y)143.52%
Cap/Depr(5y)215.73%
Cap/Sales(3y)41.48%
Cap/Sales(5y)49.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3566.67%
EPS 3Y15.79%
EPS 5YN/A
EPS Q2Q%203.77%
EPS Next Y432.73%
EPS Next 2Y138.45%
EPS Next 3Y82.97%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y22.28%
Revenue growth 5Y15.11%
Sales Q2Q%16.52%
Revenue Next Year11.36%
Revenue Next 2Y14.45%
Revenue Next 3Y10.41%
Revenue Next 5Y2.94%
EBIT growth 1Y48.37%
EBIT growth 3Y46.16%
EBIT growth 5YN/A
EBIT Next Year152.09%
EBIT Next 3Y41.35%
EBIT Next 5Y17.75%
FCF growth 1Y140.16%
FCF growth 3YN/A
FCF growth 5Y13.6%
OCF growth 1Y105.83%
OCF growth 3Y43.03%
OCF growth 5Y10.16%